Losartan Potassium
Product Images NDC 66116-415

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 66116-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B75d00af-figure-01 (69605072 F130 4054 95b0 Ff3c34554fb9 01)

Chemical structure of losartan potassium, showing its molecular components and potassium ion (K+). This structure represents the active ingredient of Losartan Potassium by MedVantx, Inc.*

FDA Label Image

B75d00af-figure-02 (69605072 F130 4054 95b0 Ff3c34554fb9 02)

A line graph comparing the percentage of patients with the primary endpoint over study months between Atenolol and Losartan Potassium. The graph shows adjusted risk reduction of 13% for Losartan Potassium with a significance of p=0.021, with the x-axis representing study months and the y-axis representing percentage of patients.*

FDA Label Image

B75d00af-figure-03 (69605072 F130 4054 95b0 Ff3c34554fb9 03)

A line graph comparing the percentage of patients with fatal/non-fatal stroke over study months for Losartan Potassium versus Atenolol. The graph shows that Losartan Potassium has a lower cumulative percentage of stroke events over time, with an indicated adjusted risk reduction of 25% (p=0.001).*

FDA Label Image

B75d00af-figure-04 (69605072 F130 4054 95b0 Ff3c34554fb9 04)

A forest plot comparing hazard ratios with 95% confidence intervals for primary composite and stroke (fatal/non-fatal) outcomes between Losartan Potassium and Atenolol. The plot includes subgroups by age, gender, race, ischemic heart disease, diabetes, and history of cardiovascular disease, showing the event rates and relative risk favoring either Losartan Potassium or Atenolol.*

FDA Label Image

B75d00af-figure-05 (69605072 F130 4054 95b0 Ff3c34554fb9 05)

Losartan Potassium 100 mg film-coated tablets carton by MedVantx, Inc. The front panel shows the product name, strength, dosage form, and labeler. The package appears white with green accents and includes basic branding and product identification details.*

FDA Label Image

B75d00af-figure-06 (69605072 F130 4054 95b0 Ff3c34554fb9 06)

Losartan Potassium tablet bottle label from MedVantx, Inc., displaying the product name prominently. The label shows a white plastic bottle with a child-resistant, white cap. The label features text with the proprietary name, some dosage and usage information, and regulatory details, including the NDC 66116-415. The background includes a faint red grid pattern on the label.*

FDA Label Image

B75d00af-figure-07 (69605072 F130 4054 95b0 Ff3c34554fb9 07)

Losartan Potassium 100 mg tablets bottle label from MedVantx, Inc. The amber plastic bottle contains 90 tablets. The label includes the product name, strength, dosage form, drug quantity, and NDC number 66116-415. The text on the label is predominantly black on a white background.*

FDA Label Image

Losartan Potassium Tablets 50mg (69605072 F130 4054 95b0 Ff3c34554fb9 08)

Label for Losartan Potassium Tablets USP 50 mg by MedVantx, Inc. The label indicates a package of 30 tablets. It includes storage instructions at controlled room temperature (25°C/77°F) with permitted excursions, dosage instructions to see package insert, and cautions to keep the container tightly closed and out of reach of children. The label also features customer service contact information and states the product is Rx Only, sample only, and not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.